Please login to the form below

Not currently logged in
Email:
Password:

Roche Diagnostics

This page shows the latest Roche Diagnostics news and features for those working in and with pharma, biotech and healthcare.

Roche collaborates with Global Fund to strengthen critical diagnostics infrastructure

Roche collaborates with Global Fund to strengthen critical diagnostics infrastructure

Schinecker, CEO of Roche Diagnostics. ... He added: “We are pleased to partner with Roche in expanding access to diagnostics tools for HIV and TB.

Latest news

  • The IMC unites health industry professionals to combat antibiotic resistant infections The IMC unites health industry professionals to combat antibiotic resistant infections

    The IMC partners are Antibiotic Research UK, the Association of British HealthTech Industries (ABHI), the Association of the British Pharmaceutical Industry (ABPI), BD, bioMérieux, the British In Vitro Diagnostics Association (BIVDA), ... the British

  • Roche acquires test maker TIB Molbiol Roche acquires test maker TIB Molbiol

    As another sign of its importance, Roche has acquired its long-term partner, diagnostics company TIB Molbiol in order to expand its test portfolio and bolster ‘the fight against new infectious ... of rare diseases,” said Thomas Schinecker, head of

  • Roche and Novartis part ways with share purchase Roche and Novartis part ways with share purchase

    Roche’s board of directors has approved the repurchase, which will be debt-financed. ... As a result, Roche will be even better positioned strategically in the future to provide life-saving medicines and diagnostics to people around the world.”.

  • Roche expands infectious disease test portfolio Roche expands infectious disease test portfolio

    PCR test specialist TIB Molbiol will join Roche to bolster its molecular diagnostics solutions for infectious diseases. ... With this acquisition, we can expand our offering of tests of existing pathogens and our response to emerging pathogens and

  • FDA approval for Roche diagnostic solid tumour test FDA approval for Roche diagnostic solid tumour test

    The Roche test evaluates a panel of MMR proteins in tumours to provide important treatment information to clinicians. ... no other suitable treatment options,” said Thomas Schinecker, CEO Roche Diagnostics.

More from news
Approximately 6 fully matching, plus 68 partially matching documents found.

Latest Intelligence

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    The FDA has just granted Roche emergency use authorisation (EUA) for its new test to detect the virus that causes the coronavirus. ... This test emerges from Roche’s diagnostics division, also headquartered in Switzerland.

  • Pharma deals in August 2015 Pharma deals in August 2015

    This situation occurred when Genentech/Roche elected not to go further with their option to acquire the epigenetics drug discovery company, Constellation Pharmaceuticals. ... Exclusive global licence. 452. GeneWEAVE. Roche. Innovative clinical

  • Diagnostics are rising up the pharma value chain Diagnostics are rising up the pharma value chain

    Pharma interview: Anssi Pulkkinen from Roche Diagnostics, Finland on the increasing prominence of diagnostics. ... lung cancer, which was backed together with Roche Diagnostics' cobas EGFR Mutation Test.

  • Interview: AstraZeneca's Susan Galbraith Interview: AstraZeneca's Susan Galbraith

    Drug discovery and development is a team sport. You can't do it really well without partnerships with academia, biotech and diagnostics companies. ... AZ is still leaving the development of companion diagnostics to external experts, however, including a

  • Deal Watch table for April 2014 Deal Watch table for April 2014

    570. Oryzon/ Roche (pRED). Early stage drug research pact. Oncology - LSD1 inhibitors, Orphan cancer blocker ORY-1001 (p1/2a for acute myeloid leukaemia). ... 521+. Iquum/ Roche. Acquisition. Molecular Diagnostics - Laboratory-in-a-tube (Liat) System. 450

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • COUCH Health taps Mark Duman for chief strategy officer role COUCH Health taps Mark Duman for chief strategy officer role

    He has over 30 years of experience working in the healthcare/pharmaceutical industries, having worked with clients including AstraZeneca, the Department of Health, Johnson &Johnson, NHS England, Novartis, Roche Diagnostics and

  • Atlas Genetics appoints Jeffery Luber as CEO Atlas Genetics appoints Jeffery Luber as CEO

    Prior to his new role at Atlas, Luber most recently led the return to growth and sale of Good Start Genetics to Invitae Corp, producing strategic partnerships with Roche Diagnostics and ... Amazon. Dr John Clarkson, founding CEO, Atlas Genetics, said:

  • Pegasus expands pharma and life sciences senior team Pegasus expands pharma and life sciences senior team

    Prior to this, Osborn worked at LEO Pharma, Roche Diagnostics and Weber Shandwick.

  • MDxHealth creates new global commercial team MDxHealth creates new global commercial team

    Skinner has over 30 years of international experience in senior sales and marketing positions with in-vitro diagnostic firms including Boehringer Mannheim (now Roche Diagnostics), Human Diagnostica, Bard Diagnostic Science, and ... Meanwhile, Dr

  • Roche's Silvia Ayyoubi retires Roche's Silvia Ayyoubi retires

    Ayyoubi will be succeeded by Cristina Wilbur, who is currently head of human resources for Roche's diagnostics division, based in Basel. ... She first joined the company's US operations in 2002 and from 2006 until 2010 was head of human resources for

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • 'Smear Word' campaign for Roche aims to break taboos and save lives

    An all-female team at Mind Matter has created a campaign for Roche that takes a tongue-in-cheek approach to tackle taboos about going for a smear test. ... She added: “From the moment we kicked off this campaign with the team at Roche Diagnostics, we

  • COUCH Health Engages Mark Duman as Chief Strategy Officer COUCH Health Engages Mark Duman as Chief Strategy Officer

    in the healthcare sector for clients including AstraZeneca, Department of Health, JnJ, Microsoft, NHS England, Novartis, Roche Diagnostics, Royal College of Surgeons, Siemens Healthineers and Tunstall Group.

  • Winners of the HSJ Partnership Awards 2019 unveiled

    Best Healthcare Provider Partnership - Roche Diagnostics and Oxford AHSN. Best Not for Profit Working in Partnership with the NHS - Breast Cancer Care, NHS Trusts and Health Boards.

  • Evoke Mind+Matter Evoke Mind+Matter

    Barrett, HealthforAnimals, Lloyds Pharmacy, Novo Nordisk, Raisio, Roche Diagnostics, Sanofi, Seqirus, SLG, Spark Therapeutics, Superdrug, Thornton &Ross, Vetoquinol, VMIC, Zogenix. ... An all-female team at Mind Matter has created a campaign for Roche

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....